Evaluation of the decellularized pulmonary valve homograft (SynerGraft™)

Journal of Heart Valve Disease

Volumn 12, Issue 6, 2003, Pages 734-740

  Bechtel, J F Matthias ^a   Müller Steinhardt, Michael ^b   Schmidtke, Claudia ^a   Brunswik, Anja ^a   Stierle, Ulrich ^a   Sievers, Hans Hinrich ^a,c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Klinik fur Herzchirurgie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; C REACTIVE PROTEIN; HLA ANTIGEN CLASS 1;

ADULT; AGE; ALLOGRAFT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; ECHOCARDIOGRAPHY; EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART VALVE REPLACEMENT; HEART VALVE STENOSIS; HEMODYNAMICS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOLOGY; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY VALVE; SAFETY; STATISTICAL SIGNIFICANCE; TEMPERATURE MEASUREMENT; TISSUE DEGENERATION;

ADULT; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; CRYOPRESERVATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY VALVE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0345134195     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Baskett RJ, Ross DB, Nanton MA, Murphy DA. Factors in the early failure of cryopreserved homograft pulmonary valves in children: Preserved immunogenicity? J Thorac Cardiovasc Surg 1996;112:1170-1179
2. Dignan R, O'Brien M, Hogan P, et al. Influence of HLA matching and associated factors on aortic valve homograft function. J Heart Valve Dis 2000;9:504-511
3. Lupinetti FM, Kneebone JM, Rekhter MD, Brockbank KGM, Gordon D. Procollagen production in fresh and cryopreserved aortic valves. J Thorac Cardiovasc Surg 1997;113:102-107
4. Tominaga T, Kitagawa T, Masuda Y, et al. Viability of cryopreserved semilunar valves: An evaluation of cytosolic and mitochondrial activities. Ann Thorac Surg 2000;70:792-795
5. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995;60:S127-S130
6. Hoekstra F, Knoop C, Vaessen L, et al. Donor-specific cellular immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg 1996;112:281-286
7. Moustapha A, Ross DB, Bittira B, et al. Aortic valve grafts in the rat: Evidence for rejection. J Thorac Cardiovasc Surg 1997;114:891-902
8. Dor FJMF, Oei FBS, Vaessen LMB, Marquet RL, Bogers AJJC, Weimar W. Frequencies of donor-reactive helper T-lymphocytes correlate with rejection of aortic valve allografts in rats. J Heart Valve Dis 2002;11:326-334
9. Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg 1998;115:111-117
10. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: Comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 1998;115:118-127
11. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg 2001;71:S428-S432
12. Elkins RC, Lane MM, Capps SB, McCue C, Dawson PE. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg 2001;13(suppl.1):82-86
13. Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-1006
14. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: A new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization. First experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999;11(suppl.1):194-200
15. Bechtel JFM, Bartels C, Schmidtke C, et al. Does histocompatibility affect homograft valve function after the Ross-procedure? Circulation 2001;104(suppl.I):I-25-I-28
16. da Costa F, Haggi H, Pinton R, Lenke W, Adam E, Costa ISEA. Rest and exercise hemodynamics after the Ross procedure: An echocardiographic study. J Card Surg 1998;13:177-185
17. Briand M, Pibarot P, Dumesmil JG, Cartier P. Midterm echocardiographic follow-up after the Ross operation. Circulation 2000;102(suppl.III):III-10-III-14
18. Ward KE, Elkins RC, Overholt ED, et al. Evaluation of cryopreserved homografts in the right ventricular outflow tract after the Ross procedure: Intermediate-term follow up. J Heart Valve Dis 1997;6:130-133
19. Carr-White GS, Kilner PJ, Hon JKF, et al. Incidence, location, pathology, and significance of pulmonary homograft stenosis after the Ross operation. Circulation 2001;104(suppl.I):I-16-I-20
20. Legare JF, Ross DB, Issekutz TB, et al. Prevention of allograft heart failure in a rat model. J Thorac Cardiovasc Surg 2001;122:310-317
21. Mitchell RN. Don't blame the lymphocyte: Immunologic processes are NOT important in tissue heart valve failure. J Heart Valve Dis 2001;10:467-470
22. Shaddy RE, Lambert LM, Fuller TC, et al. Prospective randomized trial of azathioprine in cryopreserved valved allografts in children. Ann Thorac Surg 2001;71:43-48
23. Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MH. Effect of HLA mismatching and antibody status on 'homovital' aortic valve homograft performance. Ann Thorac Surg 1998;66:S212-S215
24. Bechtel JFM, Bartels C, Schmidtke C, et al. Anti-HLA class I antibodies and pulmonary homograft function after the Ross-procedure. Ann Thorac Surg 2001;71:2003-2007
25. Elkins RC, Goldstein S, Hewitt CW, et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 2001;13(suppl.1):87-92
26. Koolbergen DR, Hazekamp MG, de Heer E, et al. The pathology of fresh and cryopreserved homograft heart valves: An analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg 2002;124:689-697
27. Villalba R, Pena J, Luque E, Gomez Villagran JL. Characterization of ultrastructural damage of valves cryopreserved under standard conditions. Cryobiology 2001;43:81-84